Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
D000284:Administration, Oral; D000758:Anesthesia / Q000009:adverse effects; D000787:Angina Pectoris / Q000188:drug therapy; D002395:Catecholamines / Q000097:blood; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D006977:Hypertension, Renal / Q000188:drug therapy; D007275:Injections, Intravenous; D007741:Labetalol / Q000009:adverse effects / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D013997:Time Factors
D002395:Catecholamines; D004983:Ethanolamines; D007741:Labetalol